INTERVIEWS

Marijuana Moment August 8, 2023

Minnesota Psychedelics Task Force Takes Shape, But Key Appointments and First Meeting Delayed

So far, 20 out of 24 appointments to the body have been made, with key outstanding positions still vacant despite a statutory requirement saying they had to be filled by July 15.

Benzinga August 6, 2023

Dua Lipa Interviews ‘Queen Of Psychedelics’ Amanda Feilding on Her 6-Decade Exploration of Psychoactive Drugs

The BBC episode moves between past and present use and research on psychedelics.

Double Blind August 3, 2023

Psilocybin Found in ‘Legal’ Amanita Muscaria Gummies at Florida Shroom Dispensary

The psychoactive compounds within the mind-altering shroom, also known as fly agaric, are not prohibited (except in Louisiana).

Psychedelic Alpha August 1, 2023

Psychedelic Naive Couple Were First to Receive Psilocybin Services in Oregon

The purpose was to ascertain the potency of the psilocybin product and refine the group’s intake process and “flow.”

Lucid News July 26, 2023

Calif. Decrim Bill Amended to Require Framework for Therapeutic Use

The amendments shift SB 58 from legislation focused on removing naturally occurring psychedelic medicines from the state’s criminal code, to one which sets the state up to build a regulated therapeutic model similar to what is under development in Oregon and Colorado.

Marijuana Moment July 24, 2023

Minneapolis Mayor Orders Psychedelics the City’s ‘Lowest Law Enforcement Priority’

Mayor Jacob Frey (D) signed the order on Friday, sending a strong message that the city does not consider substances like psilocybin to be deserving of criminalization.  

Psychedelic Spotlight July 21, 2023

SSRIs and SNRIs Appear to Weaken Psilocybin’s Effects, New Study Finds

New research suggests that although it may be relatively safe to use serotonergic antidepressants in pre-treatment time for patients with psychiatric disorders, SSRIs and SNRIs may diminish psilocybin’s effects.

Lucid News July 20, 2023

First Study to Look at Candy Flipping Suggests Potential for Psychedelic Therapy

Participants who received a combination of LSD and MDMA scored higher on measures of well-being, happiness and trust during their experience, compared to those who took LSD alone.

Green Market Report July 16, 2023

New FDA Guidance on Psychedelics Could Open Minds, Funding Sources

While researchers say the guidance will not drastically change how they study the substances, it does have an impact on two major hurdles facing the burgeoning industry: public perception and funding.

Marijuana Moment July 14, 2023

Bipartisan Lawmakers Say House Speaker Has Committed to Pushing Psychedelics Research Amendment

Reps. Dan Crenshaw (R-TX), Alexandria Ocasio-Cortez (D-NY) and Lou Correa (D-CA) held  a press conference to discuss the development and next steps.

The Dales Report July 13, 2023

Rep. Dan Crenshaw Makes Urgent Call for Support at House Rules Committee on Psychedelics

The underlying Bill, which had been previously endorsed in last year’s National Defense Authorization Act (NDAA), has encountered an obstacle during its journey as numerous progressive proposals hangs in the balance.

Marijuana Moment July 11, 2023

Massachusetts Campaign Takes First Step to Put Psychedelics Reform on the 2024 Ballot

The purpose will be to “expand mental health treatment options in Massachusetts by providing new pathways to access natural psychedelic medicine therapy.”

Marijuana Moment July 10, 2023

Berkeley, California City Council to Vote on Psychedelics Resolution This Week

The committee voted to advance the proposal, which would call on police to deprioritize enforcement of laws against all entheogenic substances, excluding peyote-derived mescaline.

The Microdose July 8, 2023

Australia’s New MDMA and Psilocybin Program Raises Concerns for Researchers

A group of researchers point to a lack of “universally accepted protocols” for psilocybin-assisted therapy to treat depression.

Green Market Report July 6, 2023

Psychedelic-Assisted Therapies Edge Closer to Insurance Coverage with New AMA Codes

Once in effect, these codes will allow physicians and other qualified health care professionals to seek coverage and reimbursement for providing psychedelic-assisted therapy, subject to approval by the U.S. Food and Drug Administration.

Marijuana Moment July 3, 2023

Bipartisan Lawmakers Applaud FDA For Publishing Psychedelics Research Guidance

FDA’s draft guidance provides scientists with a framework to carry out research that could lead to the development of psychedelic medicines.

Psychedelic Alpha June 30, 2023

Psychedelic Research Bulletin

An analysis of key research published in the past month

Double Blind June 29, 2023

California Psychedelics Legalization Bill Approved by Assembly Public Safety Committee

The legislation heads to another committee before a chance for an Assembly-wide review—but the path to approval is “narrow”

Marijuana Moment June 27, 2023

Three in Five American Voters Support Legalizing Psychedelic Therapy, New Poll Finds

And nearly half believe possession should be decriminalized for personal use for any reason.

Lucid News June 25, 2023

Report: Final Round-up from MAPS Psychedelic Science 2023

Read Lucid News’ roundup of news from the conference.